Dr. Alan R Prossin, MD

Claim this profile

The University of Texas Health Science Center at Houston

Studies Neuropsychiatric Disorders
Studies Pain
3 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.

The University Of Texas Health Science Center At Houston

Image of trial facility.

Memorial Hermann Hospital-Clinical Research Unit (MMH-CRU)

Clinical Trials Alan R Prossin, MD is currently running

Image of trial facility.

Anti-Inflammatory Drug + Pain Challenge

for Pain

The first objective of the study is to evaluate whether a novel bio-signature (derived from a wide range of pro- and anti-nociceptive IL-1 family cytokine activity) will predict pain experienced and also release of underlying endogenous opioid neurotransmitters during an experimental nociceptive pain challenge, which will be performed while simultaneously quantifying mu-opioid receptor activity in the brain via \[11C\]-carfentanil PET neuroimaging in healthy subjects. Another objective is to evaluate whether an anti-inflammatory drug that reduces activation of IL-1b (minocycline) will perturb the balance between pro- and anti-nociceptive IL-1 cytokines and effect a reduction in pain experienced (and endogenous opioids released) during the experimental, nociceptive pain challenge. A final objective is to evaluate performance characteristics (sensitivity, accuracy, dynamic range) of the biosignature for the purpose of predicting post-operative pain.

Recruiting

0 awards

Phase 1

3 criteria

Image of trial facility.

PET Imaging

for Neuropsychiatric Disorders

The purpose of this research is to determine whether there is more extensive inflammation in the brain of people with clinical evidence of neuropsychiatric syndromes, such as mood disorder, chronic pain syndrome, dementia, traumatic brain injury, or substance abuse. The research will also explore whether there is more inflammation in patients with more neuropsychiatric symptoms. Inflammation in the brain will identified by using Positron Emission Tomography (PET) with the radiotracer \[11C\]PBR-28 or \[11C\]ER176.

Recruiting

1 award

Phase 1

4 criteria

More about Alan R Prossin, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Alan R Prossin, MD has experience with

  • PET With Radiotracer [11C]PBR-28
  • PET With Radiotracer [11C]PBR-28 ( Or [11C]ER176)
  • Anakinra
  • Nociceptive Pain Challenge
  • Placebo
  • HB-adMSCs

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Alan R Prossin, MD specialize in?

Is Alan R Prossin, MD currently recruiting for clinical trials?

Are there any treatments that Alan R Prossin, MD has studied deeply?

What is the best way to schedule an appointment with Alan R Prossin, MD?

What is the office address of Alan R Prossin, MD?

Is there any support for travel costs?